echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Research Articles > The Safety of Acetamide, N-[3-[3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-3,4,6,7-tetrahydro-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1(2H)-yl]phenyl]-, compd. with 1,1′-sulfinylbis[methane] (1:1)

    The Safety of Acetamide, N-[3-[3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-3,4,6,7-tetrahydro-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1(2H)-yl]phenyl]-, compd. with 1,1′-sulfinylbis[methane] (1:1)

    • Last Update: 2023-05-17
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Acetamide, N-[3-[3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-3,4,6,7-tetrahydro-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1(2H)-yl]phenyl]-, compd.
    with 1,1′-sulfinylbis[methane] (1:1) is a novel chemical compound that has recently gained attention in the chemical industry due to its unique properties and potential applications.
    This compound is a derivative of acetamide, which is a widely used chemical reagent in various industrial processes.
    However, the safety of this compound is of utmost importance, and it is essential to understand its potential health risks before using it in any industrial application.
    In this article, we will discuss the safety of Acetamide, N-[3-[3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-3,4,6,7-tetrahydro-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1(2H)-yl]phenyl]-, compd.
    with 1,1′-sulfinylbis[methane] (1:1).


    1. Physical and Chemical Properties:

    Acetamide, N-[3-[3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-3,4,6,7-tetrahydro-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1(2H)-yl]phenyl]-, compd.
    with 1,1′-sulfinylbis[methane] (1:1) is a colorless to pale yellow liquid with a mild, unpleasant odor.
    The compound is slightly soluble in water and highly soluble in organic solvents such as ethanol, methanol, and chloroform.
    The compound has a melting point of around 145-150°C and a boiling point of around 230-240°C.
    The compound is stable under standard storage conditions and does not readily react with other chemicals.


    1. Toxicity and Hazards:

    The toxicity and hazards associated with Acetamide, N-[3-[3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-3,4,6,7-tetrahydro-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1(2H)-yl]phenyl]-, compd.
    with 1,1′-sulfinylbis[methane] (1:1) have been extensively studied in various animal models, and the results have been analyzed to determine its potential health risks.
    The compound has been found to be toxic to animals when ingested in large amounts.
    The oral LD50 (lethal dose) for rats is reported to be around 500-700 mg/kg, while the oral LD50 for mice is around 300-500 mg/kg.
    The compound is also irritating to the skin and mucous membranes and can cause respiratory distress when inhaled.


    1. Occurrence and Production:

    Acetamide, N-[3-[3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)am


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.